Valeant Pharmaceuticals International, the Canadian-based company that bought Bausch & Lomb for $8.7 billion in the spring of 2013, has lost its long and bitter battle to take over Allergan. A global leader in generic and branded drugs based in Dublin, Ireland, Actavis, has won with a friendlier bid for ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.